CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 12 enrolled
Drug / intervention
Lidocaine Digital Nerve Block +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01508832
NCT01508832Phase 4Completed
CompareCT.gov

Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers

University of California, San Francisco·interventional·Posted Jan 12, 2012·Updated Jan 30, 2020

In Brief

A Phase 4 clinical trial evaluating Lidocaine Digital Nerve Block and Bupivacaine Digital Block for Onset and Duration of a Digital Nerve Block. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The duration of the autonomic (sympathetic) block will last longer than the sensory block. The duration of the increased perfusion index will last longer than either the sympathetic or sensory block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnset and Duration of a Digital Nerve Block
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 12, 2012
Enrollment StartJan 1, 2012
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.5 years ago

Interventions

Lidocaine Digital Nerve Blockdrug

Lidocaine 1% Digital Nerve Block (2 cc

Bupivacaine Digital Blockdrug

Bupivacaine 0.25% Digital Block (2 cc)